Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Elsa M. Hjerkinn"'
Publikováno v:
International Journal of Clinical Practice. 65:939-944
Background Obese patients are at high risk of developing cardiovascular disease. Several studies suggest obesity as an independent risk factor. Adipose tissue is now accepted as an endocrine organ that produces and secretes a variety of cytokines, ho
Autor:
Christoph Kaun, Elsa M. Hjerkinn, Kurt Huber, Harald Arnesen, Thomas W. Weiss, Ingebjørg Seljeflot, Marius Trøseid, Johann Wojta
Publikováno v:
Wiener klinische Wochenschrift. 123:650-654
BACKGROUND: The metabolic syndrome (MetS) is a cluster of risk factors that are highly associated with increased risk for cardiovascular disease (CVD). Increased serum levels of plasminogen activator inhibitor-1 (PAI-1), interleukin-6 (IL-6) and IL-1
Autor:
Tor Ole Klemsdal, Jorgen Glatved Lavik, Elsa M. Hjerkinn, Øivind Ekeberg, Ingrid Ellingsen, Gunnar Einvik
Publikováno v:
Journal of Psychosomatic Research. 68:567-572
The purpose of this study is to investigate the long-term effects of participation in a cardiovascular screening program and of dietary counseling on self-reported psychosocial outcomes and health concerns.High-risk subjects (n=563) with hyperlipidem
Publikováno v:
Diabetes Care
OBJECTIVE—The aim of this study was to investigate the role of inflammatory markers as potential predictors of cardiovascular events in subjects with and without the metabolic syndrome. RESEARCH DESIGN AND METHODS—This was a post hoc analysis fro
Autor:
Harald Arnesen, I. Ellingsen, Serena Tonstad, Elsa M. Hjerkinn, I Hjermann, Ingebjørg Seljeflot
Publikováno v:
European Journal of Clinical Nutrition. 60:378-385
The Oslo Diet and Antismoking study was a 5-year randomised trial initiated in 1972-1973, which studied the effect of dietary change and smoking cessation for the prevention of coronary heart disease among high-risk middle-aged men. To test the long-
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 65:201-209
Circulating cell adhesion molecules (CAMS) are regarded as inflammatory markers related to the process of atherosclerosis and cardiovascular disease (CVD). In the haemostatic system, elevated levels of thrombomodulin (TM), von Willebrand factor (vWF)
Autor:
A. Kavlie, Ingebjørg Seljeflot, Elsa M. Hjerkinn, Marit B. Veierød, Anja Schou Lindman, Harald Arnesen, Jan I. Pedersen
Publikováno v:
Thrombosis Research. 116:313-320
0049-3848/$ see front matter D 2005 Elsevier Ltd. All rights reserv doi:10.1016/j.thromres.2004.08.031 Abbreviations: CVD, cardiovascular disease; FVII, coagulation factor FVII; FVIIa, activated FVII; FVIIag, FVII antigen; FVIIc, FVII coagulant activ
Autor:
Anja Schou Lindman, Harald Arnesen, Jan I. Pedersen, Ingrid Ellingsen, Ingebjørg Seljeflot, Marit B. Veierød, Elsa M. Hjerkinn
Publikováno v:
Thrombosis and Haemostasis. 91:1097-1104
SummaryThe aim of the present study was to investigate the effect of long-term diet and very long chain n-3 fatty acids (VLC n-3) intervention on plasma coagulation factor VII (FVII), cholinecontaining phospholipids (PC) and triglycerides (TG), espec
Autor:
Ingebjørg Seljeflot, Anja Schou Lindman, Marit B. Veierød, Jan I. Pedersen, Hans Prydz, Elsa M. Hjerkinn, Harald Arnesen
Publikováno v:
Thrombosis Research. 113:57-65
Introduction: Elevated levels of coagulation factor VII (FVII) have been associated with increased risk for myocardial infarction (MI). The R353Q polymorphism of the FVII gene has been shown to modify plasma levels of FVII, and has in some studies al
Publikováno v:
The American Journal of Clinical Nutrition. 78:935-940
Background: In the Oslo Diet and Antismoking Trial, 1232 high-risk men aged 40-49 y were randomly assigned to either a lifestyle intervention group or a control group for 5 y. The study showed a significant reduction in ischemic heart disease (IHD) e